SK280919B6 - Spôsob výroby kompozitnej vakcíny proti črevnej infekcii spôsobenej enterotoxigénnymi baktériami e. coli u ľudí - Google Patents

Spôsob výroby kompozitnej vakcíny proti črevnej infekcii spôsobenej enterotoxigénnymi baktériami e. coli u ľudí Download PDF

Info

Publication number
SK280919B6
SK280919B6 SK910-93A SK91093A SK280919B6 SK 280919 B6 SK280919 B6 SK 280919B6 SK 91093 A SK91093 A SK 91093A SK 280919 B6 SK280919 B6 SK 280919B6
Authority
SK
Slovakia
Prior art keywords
cfa
formaldehyde
bacteria
coli
antigens
Prior art date
Application number
SK910-93A
Other languages
English (en)
Slovak (sk)
Other versions
SK91093A3 (en
Inventor
Jan Holmgren
Ann-Mari Svennerholm
Original Assignee
Jan Holmgren
Ann-Mari Svennerholm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Holmgren, Ann-Mari Svennerholm filed Critical Jan Holmgren
Publication of SK91093A3 publication Critical patent/SK91093A3/sk
Publication of SK280919B6 publication Critical patent/SK280919B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK910-93A 1991-02-26 1992-02-25 Spôsob výroby kompozitnej vakcíny proti črevnej infekcii spôsobenej enterotoxigénnymi baktériami e. coli u ľudí SK280919B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9100556A SE9100556D0 (sv) 1991-02-26 1991-02-26 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e coli bacteria in humans
PCT/SE1992/000110 WO1992014487A1 (en) 1991-02-26 1992-02-25 Preparation and use of formalin-killed colonization-factor-antigen (cfa)-expressing e. coli organisms for vaccination against enteric infection/diarrhea caused by enterotoxigenic e. coli bacteria in humans

Publications (2)

Publication Number Publication Date
SK91093A3 SK91093A3 (en) 1994-05-11
SK280919B6 true SK280919B6 (sk) 2000-09-12

Family

ID=20381987

Family Applications (1)

Application Number Title Priority Date Filing Date
SK910-93A SK280919B6 (sk) 1991-02-26 1992-02-25 Spôsob výroby kompozitnej vakcíny proti črevnej infekcii spôsobenej enterotoxigénnymi baktériami e. coli u ľudí

Country Status (22)

Country Link
US (1) US6558678B1 (ru)
EP (1) EP0573527B1 (ru)
JP (1) JP3169608B2 (ru)
KR (1) KR100221452B1 (ru)
AT (1) ATE170755T1 (ru)
AU (1) AU663864B2 (ru)
BG (1) BG61683B1 (ru)
BR (1) BR9205677A (ru)
CA (1) CA2104877C (ru)
CZ (1) CZ281556B6 (ru)
DE (1) DE69226944T2 (ru)
DK (1) DK0573527T3 (ru)
ES (1) ES2123550T3 (ru)
FI (1) FI108775B (ru)
HU (1) HU213924B (ru)
NO (1) NO307867B1 (ru)
OA (1) OA09865A (ru)
RO (1) RO109819B1 (ru)
RU (1) RU2127121C1 (ru)
SE (1) SE9100556D0 (ru)
SK (1) SK280919B6 (ru)
WO (1) WO1992014487A1 (ru)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118758B1 (en) * 1997-01-24 2006-10-10 The United States Of America As Represented By The Secretary Of The Army Transformed bacteria producing CS6 antigens as vaccines
SE9401921D0 (sv) * 1994-06-03 1994-06-03 Sbl Vaccin Ab A method of cultivating bacteria
US7404961B2 (en) 1996-08-02 2008-07-29 The United States Of America As Represented By The Secretary Of The Army Peptides responsive to antibodies against consensus peptide of the CS4-CFA/I family proteins
US7094883B1 (en) 1996-08-02 2006-08-22 The United States Of America As Represented By The Secretary Of The Army Monoclonal antibody which agglutinates E. coli having the CS4-CFA/I family protein
US5994078A (en) * 1997-07-31 1999-11-30 Maine Medical Center Stable encapsulated reference nucleic acid and method of making
SE515285C2 (sv) * 1998-12-18 2001-07-09 Sbl Vaccin Ab Oralt vaccin mot diarré
GB0121998D0 (en) 2001-09-11 2001-10-31 Acambis Res Ltd Attenuated bacteria useful in vaccines
NZ547156A (en) * 2003-10-31 2009-08-28 Univ British Columbia Attenuation of A/E pathogen virulence by modulating expression of NleA
CN101378780A (zh) * 2006-02-01 2009-03-04 Sbl疫苗公司 重组细菌中的肠产毒性大肠杆菌定居因子(cf)抗原
EP2711013A4 (en) * 2011-05-18 2015-03-04 Ajinomoto Kk IMMUNSTIMULANDS FOR ANIMALS, FEED THEREFOR AND MANUFACTURING PROCESS THEREFOR
WO2013009843A1 (en) * 2011-07-11 2013-01-17 Camas Incorporated Compositions against bacterial toxins
CN103917244B (zh) 2011-09-12 2016-07-06 斯堪的纳维亚生物制药控股公司 用于提高细胞表面的etec cs6抗原呈递的方法及可由其获得的产物
WO2013037397A1 (en) 2011-09-12 2013-03-21 Scandinavian Biopharma Holding Ab Vaccine for protection against etec induced diarrhea comprising dmlt.
RO132299A3 (ro) 2017-06-06 2018-12-28 Fântână Raul Sorin Compoziţie şi metodă de preparare şi evaluare a unui imunogen complex numit i-spga, destinat producerii de proteine imunologic active ()

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD62894A (ru) *
DE1208038B (de) * 1963-08-01 1965-12-30 Wellcome Found Verfahren zur Herstellung von Impfstoffen gegen Coli-Infektionen
GB1472624A (en) * 1974-09-02 1977-05-04 Canadian Patents Dev Enteric disease vaccine
US4338298A (en) * 1980-04-04 1982-07-06 Endowment And Research Foundation At Montana State University Vaccine for passive immunization against enteric colibacillosis and method of use
DK41885A (da) * 1985-01-31 1986-11-13 Slagteriernes Forskningsinst 987p-fimbrie-producerende mikroorganisme, vaccine til immunisering af grise samt fremgangsmaade til fremstilling af vaccinen
IL79432A (en) * 1985-07-31 1992-05-25 Univ Leland Stanford Junior Unicellular microorganisms having invasive capability due to exogenous inv gene and vaccines comprising such microorganisms
FI76484C (fi) 1986-02-03 1988-11-10 Osmo Norvasto Kundstol.
JPS6399020A (ja) * 1986-06-05 1988-04-30 ベイラ−　カレツジ　オブ　メデイシン ワクチンとその製法
SU1723116A1 (ru) * 1988-04-15 1992-03-30 Оренбургский Государственный Медицинский Институт Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний
EP0433372B1 (en) * 1988-09-06 2002-06-12 Washington University Oral immunization by transgenic plants
SE9401921D0 (sv) * 1994-06-03 1994-06-03 Sbl Vaccin Ab A method of cultivating bacteria

Also Published As

Publication number Publication date
HU9302410D0 (en) 1993-11-29
EP0573527A1 (en) 1993-12-15
SE9100556D0 (sv) 1991-02-26
NO933037L (no) 1993-08-25
FI933728A0 (fi) 1993-08-25
CA2104877A1 (en) 1992-08-27
CZ174293A3 (en) 1994-04-13
DK0573527T3 (da) 1999-06-07
FI933728A (fi) 1993-10-25
EP0573527B1 (en) 1998-09-09
SK91093A3 (en) 1994-05-11
JPH06505730A (ja) 1994-06-30
HUT67198A (en) 1995-02-28
DE69226944T2 (de) 1999-02-11
US6558678B1 (en) 2003-05-06
CZ281556B6 (cs) 1996-11-13
JP3169608B2 (ja) 2001-05-28
ES2123550T3 (es) 1999-01-16
KR930703015A (ko) 1993-11-29
FI108775B (fi) 2002-03-28
CA2104877C (en) 2005-10-04
RU2127121C1 (ru) 1999-03-10
KR100221452B1 (ko) 1999-09-15
OA09865A (en) 1994-08-15
NO307867B1 (no) 2000-06-13
WO1992014487A1 (en) 1992-09-03
ATE170755T1 (de) 1998-09-15
BR9205677A (pt) 1994-05-17
RO109819B1 (ro) 1995-06-30
NO933037D0 (no) 1993-08-25
AU663864B2 (en) 1995-10-26
DE69226944D1 (de) 1998-10-15
HU213924B (en) 1997-11-28
BG98070A (bg) 1994-06-30
BG61683B1 (bg) 1998-03-31
AU1330892A (en) 1992-09-15

Similar Documents

Publication Publication Date Title
CA2198586C (en) Mutant enterotoxin effective as a non-toxic oral adjuvant
Guinée et al. Escherichia coli associated with neonatal diarrhoea in piglets and calves
Svennerholm et al. Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea
US6033673A (en) Double mutant enterotoxin for use as an adjuvant
ES2199944T3 (es) Procedimiento para la elaboracion de una cepa mutante geneticamente estable de vibrio cholerae.
Åhrén et al. Intestinal antibody response after oral immunization with a prototype cholera B subunit—colonization factor antigen enterotoxigenic Escherichia coli vaccine
JP3169608B2 (ja) ヒトにおいてエンテロトキシン産生大腸菌により起こる腸感染症／下痢に対して接種するためのホルマリン殺菌したコロニー形成因子抗原（ｃｆａ）−発現性大腸菌の調製および使用
US6436407B1 (en) Mutant enterotoxin effective as a non-toxic adjuvant
JP4516210B2 (ja) ワクチンに使用する弱毒化細菌
LEVINE et al. Pediatric diarrhea: the challenge of prevention
Richardson Animal models in cholera research
Eko et al. Immunogenicity of Vibrio cholerae ghosts following intraperitoneal immunization of mice
Lasaro et al. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli
AU774649B2 (en) Vaccine preparations containing attenuated toxin
EP1444987A2 (en) Oral vaccine against diarrhea
EP0255755A2 (en) Vaccine preparation
Svennerholm et al. Immunity to enterotoxin-producing bacteria
Gilligan et al. Oral enteric vaccines—clinical trials
Rijpkema et al. Immunoglobulins in bile and serum of the rabbit associated with protection after Vibrio cholerae infection and vaccination
OSEK et al. Enzyme‐linked immunosorbent assay for determination of antibodies to Vibrio cholere toxin‐coregulated pili
AHSAN et al. Release of endotoxin by toxigenic and non-toxigenic Vibrio cholerae 01
JAVID PREPARATION AND COMPARATIVE EVALUATION OF ANTI-IDIOTYPE VACCINE AGAINST PASTEURELLA MULTOCIDA
Azad Comparison of memory B-Cell immune responses among different age groups after oral cholera vaccination
WO2016012951A1 (en) Immunogenic conjugate
CZ20003851A3 (cs) Oslabený mutovaný kmen Salmonella a vakcína proti břišnímu tyfu